Search clinical trials for: Ecologic 825

Total 2306 results

European Organisation for Research and Treatment...

Withdrawn

CHS 828 in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

France, Norway, Switzerland, Netherlands, Belgium, Austria, United Kingdom, Denmark, Germany
Takeda

Completed

Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2
The Deutsche Diabetes Forschungsgesellschaft e.V.
Algiax Pharmaceuticals GmbH

Recruiting

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes

Type2 Diabetes

Germany
Suzhou Kintor Pharmaceutical Inc,
Suzhou Koshine Biomedica, Inc.

Active, not recruiting

Phase III Study of KX-826 With Adult Male Patients With AGA

Androgenetic Alopecia

China
Foresee Pharmaceuticals Co., Ltd.

Terminated

A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19

Severe to Critical COVID 19 With Associated ARDS

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Hepatitis C, Chronic
Rennes University Hospital

Completed

Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial (IRRICO)

Spina Bifida

France
Tongji Hospital

Completed

A Trial on Conservative Treatment for Infants' Hirschsprung Disease

Hirschsprung Disease
Millennium Pharmaceuticals, Inc.

Completed

A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer

Cancer

United States
Medical University of Graz

Active, not recruiting

Probiotics in Dementia (PIDE)

Dementia; Alzheimer, Mixed Type (Etiology)

Austria
AIDS Malignancy Consortium
National Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLC; AIDS and Cancer Specimen Resource

Terminated

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Lymphoma | Lung Cancer

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

Phase II Study Evaluating the Efficacy and Safety of KX-826

Androgenetic Alopecia (AGA)

China
Jilin University

Recruiting

Differentiation of Tubular Adenoma and Colonic Innominate Groove Under EC Endoscopy

Endocytoscopy

China
The Second Hospital of Nanjing Medical University
The First Affiliated Hospital of Guangdong Pharmaceutical University; Wuxi... and other collaborators

Not yet recruiting

Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET (RIT;TET)

Bowel Obstruction | Fecal Microbiota Transplantation

China
Janne Ladefoged Fassov
Aalborg University Hospital

Unknown

High Resolution Colonic Manometry in Relation to 3D-Transit Times in Healthy Controls.

Healthy | Colonic Motility

Denmark
Mahidol University

Completed

Stool and Serum CMV-PCR in Diagnosing CMV Colitis

CMV Colitis

Thailand
Hungarian Institute of Cardiology

Unknown

Body Composition Measurements in Chronic Heart Failure

Body Composition | Sarcopenia | Cachexia

Hungary
Blueprint Medicines Corporation

Recruiting

A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

CNS Tumor | Solid Tumor, Unspecified, Child | Relapsed Solid Neoplasm

United States, Korea, Republic of, United Kingdom, France, Canada, Australia, Austria, Germany, Italy
Millennium Pharmaceuticals, Inc.

Completed

Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)

Obstructive Sleep Apnea

United States
Takeda

Completed

Double-blind Comparative Study of TAK-875

Diabetes Mellitus

Japan
Algiax Pharmaceuticals GmbH
FGK Clinical Research GmbH

Recruiting

AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain

Peripheral Post-surgical Neuropathic Pain

Czechia, Germany, Spain, Belgium, France
Blueprint Medicines Corporation

Available

Expanded Access Program for Avapritinib

Solid Tumors
Blueprint Medicines Corporation

Active, not recruiting

Study for Patients Previously Treated in Avapritinib Clinical Trials

Gastrointestinal Stromal Tumors

France
Takeda

Completed

Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy

Healthy Participants and Patients With Narcolepsy

Japan
Blueprint Medicines Corporation

Approved for marketing

Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST

GIST
Global Alliance for TB Drug Development

Completed

A Study in Two Panels of Healthy Adult Participants to Assess Single-Dose Immediate-Release and Single-Dose Dispersible Formulations of Pretomanid

Multi-drug Resistant Tuberculosis

United States
Ain Shams Maternity Hospital

Unknown

CA-125 and Severity of Pre-Eclampsia

Pre-Eclampsia
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002)

Hepatitis C, Chronic
Biomedical Radiation Sciences
Swedish Cancer Society; Affibody

Completed

PET Study of Breast Cancer Patients Using [68Ga]ABY-025

Breast Cancer

Sweden
Henry Ford Health System

Recruiting

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Covid19

United States
BioCryst Pharmaceuticals

Completed

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Hereditary Angioedema (HAE)

Austria, Denmark, France, Germany, Hungary, Israel, Italy, North Macedonia, Poland, Romania, Switzerland, United Kingdom
University Hospital, Bordeaux

Recruiting

Mobile Technologies and Post-stroke Depression (MOTIV-POSDEP)

Depression | Stroke

France
University of Michigan

Completed

Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation

Atrial Fibrillation | Catheter Ablation

United States
Qilu Pharmaceutical Co., Ltd.

Recruiting

Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Cancer

China
Cassava Sciences, Inc.

Enrolling by invitation

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Alzheimer Disease

United States, Canada, Puerto Rico
CStone Pharmaceuticals
Blueprint Medicines Corporation

Completed

A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumors

China
Foresee Pharmaceuticals Co., Ltd.
QPS-Qualitix

Completed

Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers

Healthy

Taiwan
Takeda

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy

Healthy Participants | Narcolepsy

Japan
Tufts University

Withdrawn

Pilot Study on Weight Loss With Robotic Assistance

Weight Loss | Overweight and Obesity

United States
Abbott

Terminated

An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

Schizophrenia

United States, Argentina, Mexico
POINT Biopharma, a wholly owned subsidiary of Eli...
Eli Lilly and Company

Recruiting

[Ac-225]-PSMA-62 Trial in Biochemically Recurrent and Metastatic Castration Resistant Prostate Cancer (ACCEL)

Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | Metastatic Castration-resistant Prostate Cancer

Canada
Singapore Institute for Clinical Sciences

Recruiting

Postbiotic Intervention for Acute Stress Management (PIAS)

Sleep | Stress Response | Cognition | Mood State

Singapore
South Tyneside and Sunderland NHS Foundation Trust
University of Durham

Unknown

Detect InSpect ChAracterise Resect and Discard 2 (DISCARD2)

Colonic Polyps

United Kingdom
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Hypertension | Dyslipidemias

Korea, Republic of
University Hospital, Bordeaux
Genzyme, a Sanofi Company

Active, not recruiting

Cognition and MRI Markers in MS Patients With Aubagio® Treatment (AUBACOG)

Multiple Sclerosis, Relapsing-Remitting

France
Kartos Therapeutics, Inc.

Recruiting

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

Primary Myelofibrosis (PMF) | Post-Polycythemia Vera Myelofibrosis (Post-PV-MF) | Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF)

United States, Mexico, Bulgaria, Poland, Russian Federation, Belarus, Georgia, South Africa, Ukraine
Takeda

Active, not recruiting

A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)

Alagille Syndrome (ALGS)

Japan
Toray Industries, Inc

Completed

TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus

Uremic Pruritus

Bulgaria, Germany
Biomedical Radiation Sciences
Swedish Cancer Society

Completed

Exploratory Study of Breast Cancer With ABY025 (ABY0125)

Breast Cancer

Sweden
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828

Hypertension

Korea, Republic of

Search clinical trials for: Ecologic 825

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations